The most notable potential biomarkers for AKI-related cardiac injury include the renal protein neutrophil gelatinase-associated lipocalin, which is associated with cardiac fibrosis, fibroblast growth factor 23, which may mediate AKI-induced cardiac damage, and the cardiac injury marker galectin-3 [12]. This evidence concerns the gene LCN2 and acute kidney injury.